Genetics of melanoma tumorigenesis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 18047516.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Melanoma therapy is moving away from combinatorial approaches and towards newer targeted strategies. With the identification of mutations in various RAS pathway genes, there are now tremendous opportunities to bring inhibitors of RAS signalling to the clinical arena.
Medical subject headings
- Cell Transformation, Neoplastic
- Melanoma
- Skin Neoplasms